
Jackie Holland will join Cleary Gottlieb as a partner in the firm’s London office and focus on competition practice, including antitrust enforcement, merger control, State aid, competition litigation, and sectoral regulation.
Jackie is a leader of the UK antitrust bar. She has over 25 years’ experience in private practice and, among other things, was a Senior Director of the Office of Fair Trading, the predecessor to the Competition and Markets Authority (CMA), where she was a Phase 1 merger decision-maker, helped to reform the agency’s merger control regime and antitrust procedures, and introduced a Procedural Officer to oversee the agency’s casework.
Jackie will join Cleary Gottlieb’s leading global antitrust practice, which includes some of the most highly regarded lawyers in the field, including other former senior officials from the U.S. Federal Trade Commission, the U.S. Department of Justice, the UK CMA, and the European Commission’s Directorate-General for Competition, as well as several lawyers who have worked at the European Courts in Luxembourg.
“We are delighted to welcome Jackie to our firm,” said Cleary Gottlieb Managing Partner Michael Gerstenzang. “She brings formidable talent to our market leading competition practice.”
Jackie said, “I’m thrilled and honored to be joining Cleary Gottlieb’s outstanding competition team. Their global antitrust practice is among the best in the world, and I’m really looking forward to being part of the group. I’ve known many of the firm’s lawyers for years and have been very impressed by how quickly they’ve established one of the leading practices in town. It’s a fascinating time to be a competition lawyer in London given the CMA’s enhanced role in the post-Brexit world. I can’t wait to get started.”
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas